Psychiatric Solutions, Inc. (“PSI”) (NASDAQ: PSYS) today
announced financial results for the third quarter ended September
30, 2010. Revenue increased 12.2% for the quarter to $508.5 million
from $453.2 million for the third quarter of 2009. Income from
continuing operations attributable to PSI stockholders increased
89.7% to $53.7 million for the third quarter of 2010 from $28.3
million for the third quarter last year and 88.0% per diluted share
to $0.94 from $0.50. Results for the third quarter of 2010 included
transaction costs of approximately $2.4 million, which were related
to PSI’s previously announced definitive agreement providing for
the acquisition of PSI by Universal Health Services, Inc.
PSI’s same-facility revenue for the third quarter of 2010 grew
10.4% from the third quarter of 2009, primarily due to a 4.0%
increase in patient days and a 6.1% increase in revenue per patient
day. The Company expanded its same-facility EBITDA margin to 27.3%
for the third quarter from 20.7% for the third quarter of 2009.
Consolidated adjusted EBITDA increased 51.6% to $121.5 million, or
23.9% of revenue, for the third quarter of 2010 from $80.2 million,
or 17.7% of revenue, for the third quarter of 2009. A
reconciliation of all GAAP and non-GAAP financial results in this
release can be found on page 5.
Net cash from continuing operating activities for the third
quarter of 2010 increased 85.5% from the third quarter of 2009 to
$68.9 million. Capital expenditures, primarily for maintenance and
the addition of beds to facilities, totaled $24.8 million for the
quarter. PSI made $51.2 million of principal payments on long-term
debt during the quarter, including a $50 million optional
prepayment on its senior secured term loan. PSI’s ratio of debt to
total capitalization improved to 48.2% at the end of the third
quarter of 2010 from 50.6% at the end of the second quarter of 2010
and 56.2% at the end of the third quarter of 2009. In addition, the
ratio of debt to adjusted EBITDA for the trailing 12 months
improved to 2.8 at the end of the third quarter of 2010 from 3.3 at
the end of the second quarter of 2010 and 4.0 at the end of the
third quarter last year. PSI completed the third quarter of 2010
with $43.4 million in cash and cash equivalents and no borrowings
under its $300 million revolving credit facility.
PSI offers an extensive continuum of behavioral health programs
to critically ill children, adolescents and adults and is the
largest operator of owned or leased freestanding psychiatric
inpatient facilities with over 11,000 beds in 32 states, Puerto
Rico and the U.S. Virgin Islands. PSI also manages freestanding
psychiatric inpatient facilities for government agencies and
psychiatric inpatient units within medical/surgical hospitals owned
by others.
PSYCHIATRIC SOLUTIONS,
INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited, in thousands except for per share amounts)
Three Months Ended September 30, Nine
Months Ended September 30, 2010 2009 2010
2009 Revenue $ 508,544 $ 453,187 $ 1,487,194 $
1,342,404
Salaries, wages and employee benefits
(including share-based compensation of $4,946, $4,249, $12,738 and
$13,525 for the respective three and nine month periods in 2010 and
2009)
256,713 252,617 779,486 746,807 Professional fees 46,921 42,040
142,567 124,332 Supplies 24,350 23,137 72,332 69,549 Rentals and
leases 4,893 5,040 14,571 15,169 Other operating expenses 50,216
44,600 157,427 126,687 Provision for doubtful accounts 8,615 9,817
30,552 26,569 Depreciation and amortization 12,968 11,436 38,237
32,904 Interest expense 16,663 18,551
49,714 53,263 421,339
407,238 1,284,886 1,195,280
Income from continuing operations before income taxes 87,205
45,949 202,308 147,124 Provision for income taxes 33,277
17,651 77,572 56,380
Income from continuing operations 53,928 28,298 124,736
90,744 Loss from discontinued operations, net of taxes (796
) (153 ) (8,221 ) (464 ) Net income 53,132
28,145 116,515 90,280 Less: Net income attributable to
noncontrolling interest (247 ) 7 (297 )
(338 ) Net income attributable to PSI stockholders $ 52,885
$ 28,152 $ 116,218 $ 89,942
Basic earnings per share: Income from continuing operations
attributable to PSI stockholders $ 0.96 $ 0.51 $ 2.23 $ 1.63 Loss
from discontinued operations, net of taxes (0.01 ) -
(0.15 ) (0.01 ) Net income attributable to PSI
stockholders $ 0.95 $ 0.51 $ 2.08 $ 1.62
Diluted earnings per share: Income from continuing
operations attributable to PSI stockholders $ 0.94 $ 0.50 $ 2.19 $
1.61 Loss from discontinued operations, net of taxes (0.02 )
- (0.15 ) (0.01 ) Net income
attributable to PSI stockholders $ 0.92 $ 0.50 $ 2.04
$ 1.60 Shares used in computing per share
amounts: Basic 55,945 55,579 55,850 55,545 Diluted 57,356 56,340
56,913 56,077 Amounts attributable to PSI stockholders:
Income from continuing operations $ 53,681 $ 28,305 $ 124,439 $
90,406 Loss from discontinued operations, net of taxes (796
) (153 ) (8,221 ) (464 ) Net income $ 52,885
$ 28,152 $ 116,218 $ 89,942
PSYCHIATRIC SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in
thousands)
September 30, December 31, 2010
2009 ASSETS Current assets: Cash and
cash equivalents $ 43,422 $ 6,815
Accounts receivable, less allowance for
doubtful accounts of $53,710 and $51,894, respectively
258,822 249,439 Other current assets 94,155 105,166
Total current assets 396,399 361,420 Property and equipment, net of
accumulated depreciation 977,250 931,730 Cost in excess of net
assets acquired 1,153,111 1,153,111 Other assets 57,009
60,979 Total assets $ 2,583,769 $ 2,507,240
LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities:
Accounts payable $ 35,709 $ 35,397 Salaries and benefits payable
97,930 81,129 Other accrued liabilities 91,871 62,036 Current
portion of long-term debt 4,436 4,940 Total current
liabilities 229,946 183,502 Long-term debt, less current portion
1,075,182 1,182,139 Deferred tax liability 81,786 81,137 Other
liabilities 31,097 25,790 Total liabilities 1,418,011
1,472,568 Redeemable noncontrolling interest 4,583 4,337 Total
stockholders' equity 1,161,175 1,030,335 Total
liabilities and stockholders' equity $ 2,583,769 $ 2,507,240
PSYCHIATRIC SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
Nine Months Ended September 30, 2010
2009 Operating activities: Net income $
116,515 $ 90,280
Adjustments to reconcile net income to net
cash provided by continuing operating activities:
Depreciation and amortization 38,237 32,904 Amortization of loan
costs and bond discount 4,728 3,574 Share-based compensation 12,738
13,525 Change in income tax assets and liabilities 45,472 15,624
Loss from discontinued operations, net of taxes 8,221 464
Changes in operating assets and
liabilities, net of effect of acquisitions:
Accounts receivable (9,383 ) (4,611 ) Prepaids and other current
assets (7,527 ) 771 Accounts payable 3,606 (1,707 ) Salaries and
benefits payable 16,801 3,421 Accrued liabilities and other
liabilities (5,364 ) 995 Net cash provided by
continuing operating activities 224,044 155,240 Net cash provided
by (used in) discontinued operating activities 1,189
(252 ) Net cash provided by operating activities 225,233
154,988
Investing activities: Cash paid for
acquisitions, net of cash acquired - (32,708 ) Cash paid for real
estate acquisitions - (18,996 ) Capital purchases of property and
equipment (82,371 ) (95,392 ) Other assets 35
389 Net cash used in continuing investing activities (82,336
) (146,707 ) Net cash used in discontinued investing activities
(12 ) (221 ) Net cash used in investing activities
(82,348 ) (146,928 )
Financing activities:
Net decrease in revolving credit facility - (138,374 ) Borrowings
on long-term debt - 106,500 Principal payments on long-term debt
(109,176 ) (3,823 ) Payment of loan and issuance costs (27 ) (9,826
) Distributions to noncontrolling interests (51 ) (723 ) Excess tax
benefits from share-based payment arrangements - 208 Repurchase of
common stock upon restricted stock vesting (490 ) (992 ) Proceeds
from exercises of common stock options 3,466
1,065 Net cash used in financing activities (106,278
) (45,965 ) Net increase (decrease) in cash 36,607 (37,905 )
Cash and cash equivalents at beginning of the period 6,815
51,271 Cash and cash equivalents at end of the
period $ 43,422 $ 13,366
PSYCHIATRIC SOLUTIONS, INC. RECONCILIATION OF
INCOME FROM CONTINUING OPERATIONS TO EBITDA AND ADJUSTED EBITDA
(Unaudited, in thousands)
Three Months Ended September 30, Nine
Months Ended September 30, 2010
2009 2010 2009
Income from continuing operations attributable to PSI stockholders
$ 53,681 $ 28,305 $ 124,439 $ 90,406 Provision for income taxes
33,277 17,651 77,572 56,380 Interest expense 16,663 18,551 49,714
53,263 Depreciation and amortization 12,968 11,436
38,237 32,904 EBITDA(a) 116,589 75,943 289,962
232,953 Other expenses: Share-based compensation 4,946
4,249 12,738 13,525 Adjusted EBITDA(a) $
121,535 $ 80,192 $ 302,700 $ 246,478 (a) EBITDA and adjusted
EBITDA are non-GAAP financial measures. EBITDA is defined as income
from continuing operations attributable to stockholders before
interest expense (net of interest income), income taxes,
depreciation and amortization. Adjusted EBITDA is defined as income
from continuing operations attributable to stockholders before
interest expense (net of interest income), income taxes,
depreciation, amortization, and other items included in the caption
above labeled “Other expenses”. These other expenses may occur in
future periods but the amounts recognized can vary significantly
from period to period and do not directly relate to the ongoing
operations of our health care facilities. PSI’s management relies
on EBITDA and adjusted EBITDA as the primary measures to review and
assess operating performance of its facilities and their management
teams. PSI believes it is useful to investors to provide
disclosures of its operating results on the same basis as that used
by management. Management and investors also review EBITDA and
adjusted EBITDA to evaluate PSI’s overall performance and to
compare PSI’s current operating results with corresponding periods
and with other companies in the health care industry. You should
not consider EBITDA and adjusted EBITDA in isolation or as a
substitute for net income, operating cash flows or other cash flow
statement data determined in accordance with accounting principles
generally accepted in the United States. Because EBITDA and
adjusted EBITDA are not measures of financial performance under
accounting principles generally accepted in the United States and
are susceptible to varying calculations, they may not be comparable
to similarly titled measures of other companies.
PSYCHIATRIC SOLUTIONS, INC.
OPERATING STATISTICS - OWNED FACILITIES (Unaudited)
(Revenue in thousands) Three Months
Ended September 30, % 2010
2009 Change Same-facility results: Revenue $
464,021 $ 420,421 10.4% Admissions 48,491 44,799 8.2% Patient days
745,759 717,089 4.0% Average length of stay(a) 15.4 16.0 -3.8%
Revenue per patient day(b) $ 622 $ 586 6.1% EBITDA margin 27.3 %
20.7 % 660 bps Total facility results: Revenue $ 471,391 $
420,421 12.1% Admissions 49,573 44,799 10.7% Patient days 755,277
717,089 5.3% Average length of stay(a) 15.2 16.0 -5.0% Revenue per
patient day(b) $ 624 $ 586 6.5% EBITDA margin 27.2 % 20.7 % 650 bps
Nine Months Ended September 30, %
2010 2009 Change Same-facility results:
Revenue $ 1,353,119 $ 1,248,314 8.4% Admissions 144,482 132,881
8.7% Patient days 2,246,412 2,145,861 4.7% Average length of
stay(a) 15.5 16.1 -3.7% Revenue per patient day(b) $ 602 $ 582 3.4%
EBITDA margin 24.4 % 21.5 % 290 bps Total facility results:
Revenue $ 1,381,279 $ 1,248,314 10.7% Admissions 148,248 132,881
11.6% Patient days 2,280,722 2,145,861 6.3% Average length of
stay(a) 15.4 16.1 -4.3% Revenue per patient day(b) $ 606 $ 582 4.1%
EBITDA margin 24.3 % 21.5 % 280 bps
(a)
Average length of stay is defined as
patient days divided by admissions.
(b)
Revenue per patient day is defined as
owned facility revenue divided by patient days.
Psychiatric Solutions, Inc. (MM) (NASDAQ:PSYS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Psychiatric Solutions, Inc. (MM) (NASDAQ:PSYS)
Historical Stock Chart
From Apr 2023 to Apr 2024